The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Theratechnologies Inc down $0.08

Theratechnologies Inc is sharply lower today, dropping $0.08 or 3.51% to $2.20. Over the last five days, shares have gained 1.38% and 511.11% year to date. Shares have outperformed the S&P TSX by 311.84% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward62.13×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated August 31 1:28 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-55.86%

Theratechnologies Inc has a net profit margin of -55.86%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.65%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedMay 31, 201505/31/2015Feb 28, 201502/28/2015Nov 30, 201411/30/2014Aug 31, 201408/31/2014
Revenue7530
Total other revenue--------
Total revenue7530
Gross profit6420
Total cost of revenue1110
Total operating expense6554
Selling / general / administrative3432
Research & development1111
Depreciation / amortization0----0
Interest expense (income), net operating--------
Unusual expense (income)----00
Other operating expenses, total--------
Operating income1-1-2-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1-1-4-4
Income after tax1-1-4-4
Income tax, total0000
Net income1-1-4-4
Total adjustments to net income--------
Net income before extra. items1-1-4-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1-1-4-4
Inc. avail. to common incl. extra. items1-1-4-4
Diluted net income1-1-4-4
Dilution adjustment----00
Diluted weighted average shares61616161
Diluted EPS excluding extraordinary itemsvalue per share0.01-0.01-0.06-0.07
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.01-0.01-0.06-0.07